Tag: GCP compliance

Treatment Policy, Hypothetical and Composite Estimands: When to Use Each

Posted on By digi

Treatment Policy, Hypothetical and Composite Estimands: When to Use Each Treatment Policy, Hypothetical and Composite Estimands: When to Use Each In the realm of clinical research, particularly in the context of regulatory compliance and biostatistics, the concept of estimands has gained significant attention. Estimands provide a structured way to describe the treatment effect in clinical…

Read More “Treatment Policy, Hypothetical and Composite Estimands: When to Use Each” »

Estimands & Handling Intercurrent Events

Oversight Strategies for Direct-to-Patient IP Shipments and Returns

Posted on By digi

Oversight Strategies for Direct-to-Patient IP Shipments and Returns Oversight Strategies for Direct-to-Patient IP Shipments and Returns Clinical trials have increasingly embraced direct-to-patient (DTP) strategies, facilitated by advancements in logistics and technology. DTP clinical trials offer significant benefits, including enhanced patient engagement, expanded access to investigational products (IPs), and reduced site burden. However, they introduce unique…

Read More “Oversight Strategies for Direct-to-Patient IP Shipments and Returns” »

Oversight of DCT/Hybrid Sites

Central Monitoring Approaches Tailored to DCT/Hybrid Ecosystems

Posted on By digi

Central Monitoring Approaches Tailored to DCT/Hybrid Ecosystems Central Monitoring Approaches Tailored to DCT/Hybrid Ecosystems As clinical trials increasingly adopt decentralized clinical trial (DCT) methodologies and hybrid approaches, the need for robust central monitoring techniques becomes paramount. This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals, detailing effective central…

Read More “Central Monitoring Approaches Tailored to DCT/Hybrid Ecosystems” »

Oversight of DCT/Hybrid Sites

Detecting and Investigating Suspicious User Activity in Clinical Systems

Posted on By digi

Detecting and Investigating Suspicious User Activity in Clinical Systems Detecting and Investigating Suspicious User Activity in Clinical Systems In the landscape of clinical research, ensuring the integrity of data and the security of clinical trial systems is paramount. With the increasing reliance on electronic data capture (EDC) systems in clinical trials, the need to detect…

Read More “Detecting and Investigating Suspicious User Activity in Clinical Systems” »

Audit Trails & Access Controls

Integrating Access Management With HR, IT and Vendor Onboarding Processes

Posted on By digi

Integrating Access Management With HR, IT and Vendor Onboarding Processes Integrating Access Management With HR, IT and Vendor Onboarding Processes In the contemporary landscape of clinical trials, meticulous management of access controls is critical. As organizations progress to align their operational processes, particularly Human Resources (HR), Information Technology (IT), and vendor onboarding, there is an…

Read More “Integrating Access Management With HR, IT and Vendor Onboarding Processes” »

Audit Trails & Access Controls

Identifying and Classifying Intercurrent Events That Impact Endpoints

Posted on By digi

Identifying and Classifying Intercurrent Events That Impact Endpoints Identifying and Classifying Intercurrent Events That Impact Endpoints In the realm of clinical trials, understanding intercurrent events and their potential impact on study endpoints is crucial. This article aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a thorough, step-by-step guide to identifying and…

Read More “Identifying and Classifying Intercurrent Events That Impact Endpoints” »

Estimands & Handling Intercurrent Events

Monitoring and Quality Management in DCT and Hybrid Trial Designs

Posted on By digi

Monitoring and Quality Management in DCT and Hybrid Trial Designs In the evolving landscape of clinical research, decentralized clinical trials (DCT) and hybrid trial designs have emerged as essential methodologies, especially in the context of prostate cancer clinical trials. The complexity of these frameworks necessitates robust monitoring and quality management strategies to ensure data integrity…

Read More “Monitoring and Quality Management in DCT and Hybrid Trial Designs” »

Oversight of DCT/Hybrid Sites

Ensuring GCP Compliance Across Traditional and Virtual Site Footprints

Posted on By digi

Ensuring GCP Compliance Across Traditional and Virtual Site Footprints Ensuring GCP Compliance Across Traditional and Virtual Site Footprints In the evolving landscape of clinical research, ensuring compliance with Good Clinical Practice (GCP) remains a primary concern for clinical operations, regulatory affairs, and medical affairs professionals. This comprehensive guide outlines the steps necessary to ensure GCP…

Read More “Ensuring GCP Compliance Across Traditional and Virtual Site Footprints” »

Oversight of DCT/Hybrid Sites

What Regulators Look for in EDC, ePRO and Safety System Audit Trails

Posted on By digi

What Regulators Look for in EDC, ePRO and Safety System Audit Trails What Regulators Look for in EDC, ePRO and Safety System Audit Trails In the landscape of clinical research, maintaining data integrity and ensuring compliance with regulatory standards have become paramount. Electronic Data Capture (EDC), Electronic Patient Reported Outcomes (ePRO), and safety systems are…

Read More “What Regulators Look for in EDC, ePRO and Safety System Audit Trails” »

Audit Trails & Access Controls

Audit Trail Review Strategies for Risk-Based Monitoring and QA

Posted on By digi

Audit Trail Review Strategies for Risk-Based Monitoring and QA Audit Trail Review Strategies for Risk-Based Monitoring and QA In the progressively intricate landscape of clinical research, adhering to regulatory expectations surrounding audit trails is crucial for ensuring compliance and data integrity. This comprehensive tutorial guides clinical operations, regulatory affairs, and medical affairs professionals through the…

Read More “Audit Trail Review Strategies for Risk-Based Monitoring and QA” »

Audit Trails & Access Controls